Omeros (OMER) Capital Leases (2017 - 2018)
Omeros' (OMER) quarterly Capital Leases came in at $1.6 million in Q4 2018, up 94.81% year-on-year from $810000.0 in Q4 2017, and up 94.81% quarter-over-quarter from $810000.0 in Q4 2017.
Omeros (OMER) Capital Leases (2017 - 2018) Analysis & Trends
Omeros has disclosed Capital Leases across 2 years of filings, most recently posting $1.6 million for Q4 2018.
- Capital Leases for Q4 2018 came in at $1.6 million, up 94.81% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.6 million (up 94.81% YoY), and the FY2018 annual result was $1.6 million, up 94.81% from the prior year.
- Capital Leases came in at $1.6 million for Q4 2018 at Omeros, up from $810000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.6 million in Q4 2018 to a low of $810000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Omeros | 628.56 Mn | 493.24 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.58 Mn |
| Dec 31, 2017 | 810,000.00 |